Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristian Guja

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Maedica|August 11, 2012
Update in diabetologyCristian Guja, Radu Lichiardopol
Journal of Clinical Medicine|September 9, 2022
Nonalcoholic Fatty Liver Disease and Its Complex Relation with Type 2 Diabetes Mellitus-From Prevalence to Diagnostic Approach and Treatment StrategiesCosmina-Theodora Diaconu, Cristian Guja
Annals of Translational Medicine|December 30, 2017
Semaglutide-the "<i>new kid on the block</i>" in the field of glucagon-like peptide-1 receptor agonists?Cristian Guja, Rucsandra Dănciulescu Miulescu
Annals of Translational Medicine|December 7, 2019
Effect of type 2 diabetes medications on fracture riskCristian Guja, Loreta Guja, Rucsandra Dănciulescu Miulescu
Plos One|September 18, 2015
Structural Properties of Gene Promoters Highlight More than Two Phenotypes of DiabetesConstantin Ionescu-Tîrgovişte, Paul Aurelian Gagniuc, Cristian Guja
Biochemical and Biophysical Research Communications|March 17, 2011
Identification of gene variants in NOS3, ET-1 and RAS that confer risk and protection against microangiopathy in type 2 diabetic obese subjectsSimona-Adriana Manea, Alexandra Robciuc, Cristian Guja, et al.
Plos One|March 27, 2014
Cancer specific mortality in insulin-treated type 2 diabetes patientsSorin Ioacara, Cristian Guja, Constantin Ionescu-Tirgoviste, et al.
BMJ Open|May 27, 2022
Real-world evidence on the use of a fixed-ratio combination of insulin glargine and lixisenatide (iGlarLixi) in people with suboptimally controlled type 2 diabetes in Romania: a prospective cohort study (STAR.Ro)Cornelia Bala, Anca Cerghizan, Bogdan-Mircea Mihai, et al.
Journal of Diabetes Research|July 16, 2015
Cardiovascular Mortality in Type 2 Diabetes Patients with Incident Exposure to Insulin GlargineSorin Ioacara, Cristian Guja, Aura Reghina, et al.
Endocrine Research|January 9, 2018
All-cause and cardiovascular mortality associated with sulphonylurea and metformin therapy in type 2 diabetesSorin Ioacara, Cristian Guja, Aura Reghina, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Maedica|August 11, 2012
Update in diabetologyCristian Guja, Radu Lichiardopol
Journal of Clinical Medicine|September 9, 2022
Nonalcoholic Fatty Liver Disease and Its Complex Relation with Type 2 Diabetes Mellitus-From Prevalence to Diagnostic Approach and Treatment StrategiesCosmina-Theodora Diaconu, Cristian Guja
Annals of Translational Medicine|December 30, 2017
Semaglutide-the "<i>new kid on the block</i>" in the field of glucagon-like peptide-1 receptor agonists?Cristian Guja, Rucsandra Dănciulescu Miulescu
Annals of Translational Medicine|December 7, 2019
Effect of type 2 diabetes medications on fracture riskCristian Guja, Loreta Guja, Rucsandra Dănciulescu Miulescu
Plos One|September 18, 2015
Structural Properties of Gene Promoters Highlight More than Two Phenotypes of DiabetesConstantin Ionescu-Tîrgovişte, Paul Aurelian Gagniuc, Cristian Guja
Biochemical and Biophysical Research Communications|March 17, 2011
Identification of gene variants in NOS3, ET-1 and RAS that confer risk and protection against microangiopathy in type 2 diabetic obese subjectsSimona-Adriana Manea, Alexandra Robciuc, Cristian Guja, et al.
Plos One|March 27, 2014
Cancer specific mortality in insulin-treated type 2 diabetes patientsSorin Ioacara, Cristian Guja, Constantin Ionescu-Tirgoviste, et al.
BMJ Open|May 27, 2022
Real-world evidence on the use of a fixed-ratio combination of insulin glargine and lixisenatide (iGlarLixi) in people with suboptimally controlled type 2 diabetes in Romania: a prospective cohort study (STAR.Ro)Cornelia Bala, Anca Cerghizan, Bogdan-Mircea Mihai, et al.
Journal of Diabetes Research|July 16, 2015
Cardiovascular Mortality in Type 2 Diabetes Patients with Incident Exposure to Insulin GlargineSorin Ioacara, Cristian Guja, Aura Reghina, et al.
Endocrine Research|January 9, 2018
All-cause and cardiovascular mortality associated with sulphonylurea and metformin therapy in type 2 diabetesSorin Ioacara, Cristian Guja, Aura Reghina, et al.
Pageof 7